Traduction de «safety and hazard investigation » (Néerlandais → Français) :

U.S. Chemical Safety and Hazard Investigation Board (in het Engels):
U.S. Chemical Safety and Hazard Investigation Board (en anglais):

De leidraad is beschikbaar in het Engels en Duits en u kan die raadplegen op de website van BAuA: Announcement on Hazardous Substances 409 - Using REACH-information for health and safety at work.
Le guide est disponible en anglais et en allemand et vous pouvez le consulter sur le site du BAuA: Announcement on Hazardous Substances 409 - Using REACH-information for health and safety at work.

Publicatie ‘Safety Information’ van de ‘European Industrial Gases Association’ (EIGA): Oxygen Deficiency Hazard associated with Hypoxic Fire Suppression Systems using Nitrogen Injection (PDF)
Publication ‘Safety Information’ de l’ ‘European Industrial Gases Association’ (EIGA): Oxygen Deficiency Hazard associated with Hypoxic Fire Suppression Systems using Nitrogen Injection (PDF)

Op de website van het Amerikaanse National Institute for Occupational Safety and Health (NIOSH) (in het Engels): Reducing noise hazards for call and dispatch center operators (PDF)
Sur le site Internet de l’Amerikaanse National Institute for Occupational Safety and Health (NIOSH) (en anglais): Reducing noise hazards for call and dispatch center operators (PDF)

The safety of participants in clinical trials with investigational products (IMP) and of the users of the authorised medicines and health products is of fundamental importance.
The safety of participants in clinical trials with investigational products (IMP) and of the users of the authorised medicines and health products is of fundamental importance.

in healthy volunteers and patients. This entails investigating the safety and efficacy of increasing doses of the product and the pharmacokinetics in phase I and early phase II trials.
in healthy volunteers and patients. This entails investigating the safety and efficacy of increasing doses of the product and the pharmacokinetics in phase I and early phase II trials.